MedTrace Logo

Pancreas Cancer Surveillance Using an Abbreviated MRI

NCT04592393 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-08-18

No results posted yet for this study

Summary

This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.

Conditions

  • Pancreas Cancer

Interventions

DIAGNOSTIC_TEST

Abbreviated PB MRI

Annual non-contrast PB MRI.

GENETIC

Gene mutation test

K-ras and GNAS mutation test. Being performed once as a baseline test at the enrollment.

DIAGNOSTIC_TEST

Conventional follow-up

Any of followings: scheduled CECT, MRI, USG, EUS, tumor marker (CA 19-9) during the study period.

Sponsors & Collaborators

Principal Investigators

  • Jeong Min Lee, MD · Professor

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04592393 on ClinicalTrials.gov